NRx Pharmaceuticals Completes Enrollment for Bipolar Depression Trial, Eyes Q2 Readout
RADNOR, PA — Pennsylvania-based biopharmaceutical company NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced a significant development in its ongoing clinical trial for a novel treatment for bipolar depression. The company …
NRx Pharmaceuticals Completes Enrollment for Bipolar Depression Trial, Eyes Q2 Readout Read More